News – Page 125 – Endpoints News

SK to pay up to $571M in new radiopharma deal; Aslan lets go of all employees

10 months ago

‘Search mode’: Human challenge trial company looks to buy small CROs

10 months ago

Cassava founder and CEO resigns as federal probes progress

10 months ago

AI drug development company gets $80M backing from Pfizer, Nvidia and Thermo Fisher

10 months ago

Roche declares early win for oral GLP-1 drug it bought from Carmot

10 months ago

Three months after delisting, NGM Bio is back with $122M for slimmed-down pipeline

10 months ago

4DMT builds out case for wet AMD gene therapy with new Phase 2 data

10 months ago

Investment firm launches with $100M for bioprocessing entrepreneurs

10 months ago

Genentech parts ways with Relay Therapeutics on SHP2 after other pharma exits

10 months ago

Adverum prepares pivotal study for wet AMD gene therapy, touts Phase 2 data

10 months ago

Caribou to slash preclinical allogeneic CAR-NK work, lay off 12% of staff

10 months ago

Renalys raises $37.8M to take Travere's kidney disease drug into Phase 3 trial in Japan

10 months ago

After a handful of stumbles, argenx doubles down on pipeline-in-a-product strategy as it pitches investors

10 months ago

FDA again rejects Orexo's nasal spray for opioid overdose rescue

10 months ago

Biotech industry flirts with XBI milestone as it surpasses $100

10 months ago

Large group of state attorneys general backs Oregon drug price transparency law

10 months ago

Federal judge dismisses Hawaii’s lawsuit against top three PBMs

10 months ago

AstraZeneca criticizes CMS guidance in appeal over price negotiations

10 months ago

FDA warns Chinese drugmaker for serious GMP record violations

10 months ago

SOTIO, Biocytogen to jointly develop antibodies; Pliant's mid-stage liver disease data

10 months ago

Q&A: Jefferies analyst Brian Tanquilut talks Walgreens’ retreat from primary care and what’s sinking retailers’ ...

10 months ago

A teenager faced constant seizures. Could a drug developed just for him stop them?

10 months ago

Scorpion raises $150M with sights on the next wave of targeted therapies

10 months ago

Sionna licenses clinical-stage cystic fibrosis assets from AbbVie shortly after large Series C

10 months ago

First page Previous page 122 123 124125126 127 128 Next page Last page